Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of a Screening Tool for Subjects With Benign Prostatic Enlargement/Obstruction to Identify Men >=50 Years Presenting in General Practice With Other Co-morbidities Who Should be Assessed for BPH

NCT02757963 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02757963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02757963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of a Screening Tool for Subjects With Benign Prostatic Enlargement/Obstruction to Identify Men >=50 Years Presenting in General Practice With Other Co-morbidities Who Should be Assessed for BPH
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
May 12, 2016
Completion date
February 27, 2017
Enrollment
1,679 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia